AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
POLYMYXIN B SULPHATE
5 registrations across 4 African markets— 5 active
Markets with POLYMYXIN B SULPHATE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| POLY M&B INJECTION | 🇬🇭Ghana | — | active | Sept 2029 |
| POLY M&B INJECTION | 🇬🇭Ghana | — | active | Sept 2029 |
| POLY-MXB POWDER/INJECTABLE; INJECTION | 🇿🇼Zimbabwe | BHARAT SERUMS & VACCINES LTD | active | Dec 2027 |
| Polaxin B** Freeze-dried powder for injection | 🇳🇬Nigeria | Chanrai HealthCare Limited | active | Oct 2025 |
| Poly-MxB Lyophilized Injection | 🇹🇿Tanzania | Bharat Serums and Vaccines Limited | active | — |
POLYMYXIN B SULPHATE in Africa — Regulatory Overview
POLYMYXIN B SULPHATE is registered across 4 African markets with 5 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Nigeria, Tanzania, Zimbabwe. AfricaRegulatory refreshes this data daily from official government sources.
Of the 5 registrations, 5 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.